U-Blot® Research Grade AbituzumabCat. No. WA1012Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AbituzumabCat. No. WA1012
U-Blot® Research Grade AbiprubartCat. No. WA1011
U-Blot® Research Grade AbelacimabCat. No. WA1010
U-Blot® Research Grade abdakibartCat. No. WA1009
U-Blot® Research Grade AbciximabCat. No. WA1008
U-Blot® Research Grade abazistobartCat. No. WA1007
U-Blot® Research Grade AbataceptCat. No. WA1006
U-Blot® Research Grade AbagovomabCat. No. WA1005
U-Blot® Research Grade 4F2MabCat. No. WA1004
U-Blot® Research Grad Eftansomatropin alfaCat. No. WA1003
U-Blot® Resaerch Grade Anti-EGFRvIII Antibody (AMG-595)Cat. No. WA1002
U-Blot® Research Grade zumilokibartCat. No. WA1001